Clinical Trial Update: Concurrent Immunotherapy With Postoperative Radiotherapy in Intermediate/High Risk HNSCC Patients Unfit for Cisplatin: The IMPORT Study (IMPORT) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent immunotherapy with postoperative radiotherapy in intermediate/high-risk head and neck squamous cell carcinoma patients unfit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN